Cassava Sciences Inc.

NASDAQ: SAVA · Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Aug 15, 2025, 3:59 PM
2.33
-0.85%
After-hours: Aug 15, 2025, 07:46 PM EDT

Cassava Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2.35M 2.35M 2.35M 2.35M -1.8K -1.8K -1.8K -1.8K -200 -200 -200 -200 n/a n/a n/a
Cost of Revenue
300K 611K 967K 1.36M 1.45M 1.53M 1.56M 1.47M 1.38M 1.3M 1.23M 1.14M 846K 534K 567K 355.4K 593.4K
Gross Profit
-300K -611K 1.38M 989K 898K 818K -1.56M -1.47M -1.38M -1.3M -1.23M -1.14M -846.2K -534.2K -567K -355.4K -593.4K
Operating Income
-151.9M -147.25M -140.55M -137.8M -99.38M -106.35M -104.5M -97.96M -89.1M -80.02M -73.53M -61.94M -47.16M -32.87M -21.05M -12.73M -8.76M
Interest Income
8M 8.51M 8.29M 7.68M 7.56M 7.83M 7.81M 6.68M 4.8M 2.78M 1.24M 374K 73K 49K 41K 33K 47K
Pretax Income
-72.79M -24.34M -17.66M -15.37M -47.9M -97.22M -95.43M -90.04M -82.99M -76.25M -71.28M -60.59M -46.39M -32.38M -20.83M -12.7M -8.71M
Net Income
-72.79M -24.34M -17.66M -15.37M -47.9M -94.58M -91M -84.52M -76.56M -72.16M -69M -59.39M -46.09M -32.38M -20.83M -12.7M -8.71M
Selling & General & Admin
84.53M 77M 71.74M 63.07M 15.18M 16.18M 15.76M 14.3M 13.46M 11.99M 12.8M 11.7M 9.97M 8.05M 5.06M 4.38M 3.96M
Research & Development
67.07M 69.64M 67.84M 73.77M 83.54M 89.42M 88.34M 83.27M 75.25M 68.03M 60.72M 50.24M 37.19M 24.81M 15.99M 8.35M 5.04M
Other Expenses
99K 259K 259K 482K 586K 616K 865K 852K 924K 997K 1.01M 972K 697K 434K 176K n/a n/a
Operating Expenses
151.34M 146.38M 139.58M 136.84M 98.71M 105.6M 104.11M 97.57M 88.71M 80.02M 73.53M 61.94M 47.16M 32.87M 21.05M 12.73M 9M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
5.5M 5.19M 4.83M 4.83M -667K -356K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
147.32M 142.67M 140.55M 137.8M 99.38M 105.96M 104.11M 97.57M 88.71M 80.02M 73.53M 61.94M 47.16M 32.87M 21.05M 12.73M 9M
Income Tax Expense
n/a n/a n/a n/a n/a -2.63M -4.43M -5.52M -6.43M -4.09M -2.29M -1.2M -307K -20K -20K -27K -41K
Shares Outstanding (Basic)
48.26M 48.1M 47.98M 46.2M 43M 42.19M 42M 41.79M 41.74M 40.77M 40.05M 40.02M 39.96M 39.96M 39.96M 39.95M 37.72M
Shares Outstanding (Diluted)
48.26M 48.1M 47.98M 46.2M 44.1M 42.19M 42M 41.79M 41.74M 40.77M 40.05M 40.02M 39.96M 39.96M 39.96M 39.95M 37.72M
EPS (Basic)
-1.53 -0.47 -0.37 -0.4 -1.16 -2.26 -2.19 -2.06 -1.89 -1.8 -1.72 -1.48 -1.15 -0.81 -0.55 -0.37 -0.28
EPS (Diluted)
-1.52 -1.47 -1.38 -1.41 -2.17 -2.26 -2.19 -2.06 -1.89 -1.8 -1.72 -1.48 -1.15 -0.81 -0.55 -0.37 -0.28
EBITDA
-145.66M -140.91M -134.61M -130.63M -97.93M -104.43M -102.54M -96.1M -87.33M -78.72M -72.3M -60.8M -46.31M -32.33M -20.83M -12.72M -8.99M
EBIT
-144.21M -139.56M -134.75M -132M -99.38M -105.96M -104.11M -97.57M -88.71M -80.02M -73.53M -61.94M -47.16M -32.87M -21.05M -12.73M -9M
Depreciation & Amortization
819K 1.13M 1.23M 1.36M 1.45M 1.53M 1.56M 1.47M 1.38M 1.3M 1.23M 1.14M 846K 534K 222K 11K 9K